Cargando…
COVID-19 and Inflammatory Bowel Diseases: Risk Assessment, Shared Molecular Pathways, and Therapeutic Challenges
BACKGROUND: The novel coronavirus SARS-CoV-2 causing COVID-19 disease is yielding a global outbreak with severe threats to public health. In this paper, we aimed at reviewing the current knowledge about COVID-19 infectious risk status in inflammatory bowel disease (IBD) patients requiring immunosupp...
Autores principales: | Popa, Iolanda Valentina, Diculescu, Mircea, Mihai, Cătălina, Cijevschi-Prelipcean, Cristina, Burlacu, Alexandru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352130/ https://www.ncbi.nlm.nih.gov/pubmed/32714386 http://dx.doi.org/10.1155/2020/1918035 |
Ejemplares similares
-
A Machine Learning Model Accurately Predicts Ulcerative Colitis Activity at One Year in Patients Treated with Anti-Tumour Necrosis Factor α Agents
por: Popa, Iolanda Valentina, et al.
Publicado: (2020) -
Ischemic Heart Disease in Patients with Inflammatory Bowel Disease: Risk Factors, Mechanisms and Prevention
por: Jucan, Alina Ecaterina, et al.
Publicado: (2022) -
What is the impact of age on adult patients with inflammatory bowel disease?
por: PRELIPCEAN, CRISTINA CIJEVSCHI, et al.
Publicado: (2013) -
Impact of COVID-19 Pandemic on the Quality of Life of IBD Patients
por: Gavrilescu, Otilia, et al.
Publicado: (2022) -
Anemia in Crohn’s Disease—The Unseen Face of Inflammatory Bowel Disease
por: Dranga, Mihaela, et al.
Publicado: (2021)